Diabetes Information

  • Diabetes Educators Slider

    We believe: The greatest solutions arise from collaboration.

    Evidence + Judgment = Best Care

    Start Here

Latest Updates

Apotex Inc. is recalling eight lots of its 500 mg extended release metformin tablets (“APO-Metformin ER”) because they contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) above the acceptable limit. Apotex Inc. has tested all lots of its 500 mg extended release tablets; only the affected lots are being recalled. Impacted patients are to talk to their pharmacists and prescribers prior to stopping their doses.

Please read the Health Canada Alert. 

Diabetes Update Sign-Up

Stay up-to-date with diabetes education and management. Receive updates on new medications, products, continuing education for healthcare professionals and more by signing up for our periodic emails.

To view past updates, please visit our archives.